Current chemotherapy arsenal for schistosomiasis mansoni: Alternatives and challenges

Parasitology Research

Volumn 104, Issue 5, 2009, Pages 955-965

  Abdul Ghani, Rashad ^a   Loutfy, Naguiba ^b   Sahn, Amel El ^b   Hassan, Azza ^b  

^a SANA A UNIVERSITY   (Yemen)

^b High Institute of Public Health Egypt   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISCHISTOSOMAL AGENT; ARTEETHER; ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; DIHYDROARTEMISININ DERIVATIVE; HEMIN; K 11777; MIRAZID; MYRRH EXTRACT; OXADIAZOLE DERIVATIVE; OXAMNIQUINE; OZ 209; OZ 277; OZ 288; OZ 709; OZ 78; PHOSPHINIC ACID DERIVATIVE; PLANT EXTRACT; PRAZIQUANTEL; TRIOXOLANE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; CHEMOPROPHYLAXIS; CHEMOTHERAPY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG SENSITIVITY; ENANTIOMER; FASCIOLIASIS; HUMAN; IMMUNITY; INTESTINAL SCHISTOSOMIASIS; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REINFECTION; REVIEW; SCHISTOSOMA; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMIASIS MANSONI; SINGLE DRUG DOSE; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTHELMINTICS; DRUG RESISTANCE; HUMANS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

SCHISTOSOMA MANSONI;

EID: 62949088164     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-009-1371-7     Document Type: Review

References (108)

1. SS Abdel Aziz NM el-Badawy 2000 Experimental trials of an artemisinin derivative in treatment of Schistosoma mansoni infected mice J Egypt Soc Parasitol 30 295 303
2. MH Abdulla KC Lim M Sajid JH Mckerrow CR Caffrey 2007 Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor PloS Med 4 e14
3. AA Abo-Madyan TA Morsy SM Motawea 2004 Efficacy of Myrrh in the treatment of schistosomiasis (haematobium and mansoni) in Ezbet El-Bakly, Tamyia Center, El-Fayoum Governorate, Egypt J Egypt Soc Parasitol 34 423 446
4. F Badria G Abou-Mohamad A El-Mowafy A Masoud O Salama 2001 Mirazid: a new schistosomicidal drug Pharmaceut Biol 39 127 131
5. R Barakat H Elmorshedy A Fenwick 2005 Efficacy of myrrh in the treatment of human schistosomiasis mansoni Am J Trop Med Hyg 73 365 367
6. NR Bergquist DG Colley 1998 Schistosomiasis vaccines: research to development Parasitol Today 14 99 104
7. R Bergquist J Utzinger J Cholett SH Xiao NA Weiss M Tanner 2004 Triggering of high-level resistance against Schistosoma mansoni reinfection by artemether in the mouse model Am J Trop Med Hyg 71 774 777
8. S Botros A Soliman N el-Gawhary M Selim N Guirguis 1989 Effect of combined low dose praziquantel and oxamniquine on different stages of schistosome maturity Trans R Soc Trop Med Hyg 83 86 89
9. S Botros S William F Ebeid D Cioli N Katz TA Day JL Bennett 2004 Lack of evidence for an antischistosomal activity of myrrh in experimental animals Am J Trop Med Hyg 71 206 210
10. S Botros H Sayed H El-Dusoki H Sabry I Rabie M El-Ghannam M Hassanein Y Abd El-Wahab D Engles 2005 Efficacy of Mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households Am J Trop Med Hyg 72 119 123
11. PJ Brindley M Strand AP Norden A Sher 1989 Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens Mol Biochem Parasitol 34 99 108
12. PJ Brindley A Sher 1987 The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response J Immunol 139 215 220
13. CR Caffrey 2007 Chemotherapy of schistosomiasis: present and future Curr Opin Chem Biol 11 433 439
14. DJ Chen LF Fu PP Shao FZ Wu CZ Fan H Shu CS Ren XL Sheng 1980 Studies on antischistosomal activity of qinghaosu in experimental therapy Zhong Hui Yi Xue Zha Zhi 80 422 428
15. L Chitsulo D Engles A Montresor L Savioli 2000 The global status of schistosomiasis and its control Acta Trop 77 41 51
16. D Cioli L Pica-Mattoccia S Archer 1995 Antischistosomal drugs: past, present...and future Pharmacol Ther 68 35 85
17. AM Creasey P Taylor JE Thomas 1986 Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren Cent Afr J Med 32 165 167
18. D De Clercq J Vercruysse M Picquet DJ Shaw M Diop A Ly B Gryseels 1999 The epidemiology of a recent focus of mixed Schistosoma haematobium and Schistosoma mansoni infections around the 'Lac de Guiers' in the Senegal River Basin, Senegal Trop Med Int Health 4 544 550
19. D De Clercq J Vercruysse P Verlé A Kongs M Diop 2000 What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections? Trop Med Int Health 5 744 746
20. MJ Doenhoff J Modha JR Lambertucci 1988 Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase Immunol 65 507 510
21. D Engels L Chitsulo A Montresor L Savioli 2002 The global epidemiological situation of schistosomiasis and new approaches to control and research Acta Trop 82 139 146
22. PG Fallon RO Cooper AJ Probert MJ Doenhoff 1992 Immune-dependent chemotherapy of schistosomiasis Parasitology 105 S41 S48
23. PG Fallon RF Sturrock AC Niang MJ Doenhoff 1995 Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni Am J Trop Med Hyg 53 61 62
24. PG Fallon LF Tao MM Ismail JL Bennett 1996 Schistosome resistance to praziquantel: fact or artifact Trends Parasitol 12 316 320
25. PG Fallon RE Fookes GA Wharton 1996 Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for Drug-antibody synergy Parasitology 112 47 58
26. PG Fallon JS Mubarak RE Fookes M Niang AE Butterworth RF Sturrock MJ Doenhoff 1997 Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates Exp Parasitol 86 29 36
27. A Fenwick L Savioli D Engels NR Bergquist MH Todd 2003 Drugs for the control of parasitic diseases: current status and development in schistosomiasis Trends Parasitol 19 509 515
28. R Foster ET Mesmer BL Cheetham DF King 1971 The control of immature Schistosoma mansoni in mice by UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative Ann Trop Med Parasitol 65 221 232
29. RF Genovese DB Newman TG Brewer 2000 Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats Pharmacol Biochem Behav 67 37 44
30. J Golenser JH Waknine M Krugliak NH Hunt GE Grau 2006 Current perspectives on the mechanism of action of artemisinins Int J Parasitol 36 1427 1441
31. R Gönnert P Andrews 1977 Praziquantel, a new broad-spectrum antischistosomal agent Z Parasitenkd 52 129 150
32. 2+ channels targets of praziquantel action? Int J Parasitol 35 1 9
33. DA Greene 1993 Gold, frankincense, myrrh, and medicine N C Med J 54 620 622
34. B Gryseels 2000 Schistosomiasis vaccines: a devils' advocate view Parasitol Today 16 46 48
35. B Gryseels A Mbaye SJ De Vlas FF Stelma F Guissé L van Lieshout D Faye M Diop A Ly LA Tchuem-Tchuenté D Engels K Polman 2001 Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence Trop Med Int Health 6 864 873
36. B Gryseels K Polman J Clerinx L Kestens 2006 Human schistosomiasis Lancet 368 1106 1118
37. W Harnett JR Kusel 1986 Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro Parasitology 93 401 405
38. M Hassan M El-Motaiem H Afify B Abaza M El-Shafie AM Massoud 2003 In vitro effect of Mirazid on Schistosoma mansoni worms J Egypt Soc Parasitol 33 999 1008
39. GR Hillman AW Senft WB Gibler 1978 The mode of action of hycanthone revisited J Parasitol 64 754 756
40. PJ Hotez DH Molyneux A Fenwick E Ottessen S Ehrlich Sachs JD Sachs 2006 Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria PLoS Med 3 e102
41. MM Ismail SA Taha AM Farghaly AS el-Azony 1994 Laboratory induced resistance to praziquantel in experimental schistosomiasis J Egypt Soc Parasitol 24 685 695
42. M Ismail A Metwally A Farghaly J Bruce L-F Tao JL Bennett 1996 Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate highly doses of praziquantel Am J Trop Med Hyg 55 214 218
43. M Ismail S Botros A Metwally S William A Farghaly L-F Tao TA Day JL Bennett 1999 Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers Am J Trop Med Hyg 60 932 935
44. MC Jeziorski RM Greenberg 2006 Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action Int J Parasitol 36 625 632
45. P Kallestrup R Zinyama E Gomo AE Butterworth GJ van Dam J Gerstoft C Erikstrup H Ullum 2006 Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection Clin Infect Dis 42 1781 1789
46. S Kaojarern S Nathakarnkikool U Suvanakoot 1989 Comparative bioavailability of praziquantel tablets DICP: The Annals of Pharmacotherapy 23 29 32
47. DM Karanja AE Boyer M Strand DG Colley BL Nahlen JH Ouma WE Secor 1998 Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1 Am J Trop Med Hyg 59 307 311
48. N Katz 1999 Schistosomiasis vaccines: the need for more research before clinical trials Parasitol Today 15 165 166
49. N Katz PMZ Coelho 2008 Clinical therapy of schistosomiasis mansoni: The Brazilian contribution Acta Trop 108 72 78
50. N Katz EP Dias N Arau'jo CP Souza 1973 Estudo de uma cepa humana de Schistosoma mansoni resistente a agentes esquistossomicidas Rev Soc Bras Med Trop 6 381 387
51. B Kaye NM Woolhouse 1976 The metabolism of oxamniquine-a new schistosomicide Ann Trop Med Parasitol 70 323 328
52. J Keiser J Utzinger M Tanner Y Dong JL Vennerstrom 2006 The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica J Antimicrob Chemother 58 1193 1197
53. DL Klayman 1985 Qinghaosu (artemisinin): an antimalarial drug from China Science 228 1049 1055
54. GO Kokwaro G Taylor 1991 Oxamniquine pharmacokinetics in healthy Kenyan African volunteers East Afr Med J 68 359 364
55. AN Kuntz E Davioud-Charvete AA Sayed LL Califf J Dessolin ESJ Arnér DL Williams 2007 Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target PloS Med 4 e206
56. JR Kusel FA Oliveira M Todd F Ronketti SF Lima AC Mattos KT Reis PM Ceolho JA Thornhill F Ribeiro 2006 The effects of drugs, ions, and poly-l-lysine on the excretory system of Schistosoma mansoni Mem Inst Oswaldo Cruz 101 293 298
57. JR Lambertucci J Modha MJ Doenhoff 1989 Schistosoma mansoni: the therapeutic efficacy of oxamniquine is enhanced by immune serum Trans R Soc Trop Med Hyg 83 362 363
58. WJ Le JQ You YQ Yang JY Mei HF Guo HZ Yang CW Zhang 1982 Studies on the efficacy of artemether in experimental schistosomiasis Acta Pharm Sin 17 187 193
59. WJ Le JQ You JY Mei 1983 Chemotherapeutic effect of artesunate in experimental schistosomiasis Acta Pharm Sin 18 619 621
60. MR Mahmoud SS Botros 2005 Artemether as adjuvant therapy to praziquantel in murine Egyptian schistosomiasis mansoni J Parasitol 91 175 178
61. H Mehlhorn B Becker P Andrews H Thomas JK Frenkel 1981 In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. (A light and electron microscopic study) Arzneim Forsch/Drug Res 31 544 554
62. J Modha JR Lambertucci MJ Doenhoff DJ McLaren 1990 Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo Parasite Immunol 12 321 334
63. J Pellegrino FF Lima-Costa MA Carlos RT Mello 1977 Experimental chemotherapy of schistosomiasis mansoni. XIII. Activity of praziquantel, an isoquinoline-pyrazino derivative, on mice, hamsters and Cebus monkeys Z Parasitenkd 52 151 168
64. C Pereira PG Fallon J Cornette A Capron MJ Doenhoff RJ Pierce 1998 Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni Parasitology 117 63 73
65. L Pica-Mattoccia D Cioli 1986 Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs J Parasitol 72 531 539
66. L Pica-Mattoccia D Cioli S Archer 1989 Binding of oxamniquine to the DNA of schistosomes Trans R Soc Trop Med Hyg 83 373 376
67. L Pica-Mattoccia LCD Dias R Moroni D Cioli 1993 Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/ oxamniquine-resistant strains are mutated in the same gene Exp Parasitol 77 445 449
68. L Pica-Mattoccia D Carlini A Guidi V Cimica F Vigorosi D Cioli 2006 The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase Mem Inst Oswaldo Cruz 101 307 312
69. L Pica-Mattoccia C Valle A Basso AR Troiani F Vigorosi P Liberti A Festucci D Cioli 2007 Cytochalasin D abolishes the schistosomicidal activity of praziquantel Exp Parasitol 115 344 351
70. M Picquet J Vercruysse DJ Shaw M Diop A Ly 1998 Efficacy of praziquantel against Schistosoma mansoni in northern Senegal Trans R Soc Trop Med Hyg 92 90 93
71. R Price M van Vugt L Phaipun C Luxemburger J Simpson R McGready F ter Kuile A Kham T Chongsuphajaisiddhi NJ White F Nosten 1999 Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives Am J Trop Med Hyg 60 547 555
72. RN Pugh CH Teesdale 1983 Synergy of concurrent low dose oxamniquine and praziquantel in schistosomiasis Br Med J 287 877 878
73. F Ribeiro PM Coelho LQ Vieira DG Watson JR Kusel 1998 The effect of praziquantel treatment on glutathione concentration in Schistosoma mansoni Parasitology 116 229 236
74. F Ribeiro RT Mello CA Tavares JR Kusel PM Coelho 2004 Synergistic action of praziquantel and host specific immune response against Schistosoma mansoni at different phases of infection Rev Inst Med Trop Sao Paulo 46 231 233
75. HC Richards R Foster 1969 A new series of 2- aminomethyltetrahydroquinoline derivatives displaying schistosomicidal activity in rodents and primates Nature 222 581 582
76. AA Sayed A Simeonov CJ Thomas J Inglese CP Ausin DL Williams 2008 Identification of oxadiazoles as new drug leads for the control of schistosomiasis Nat Med 14 407 412
77. JR Shaw KW Brammer 1983 The treatment of experimental schistosomiasis with a combination of oxamniquine and praziquantel Trans R Soc Trop Med Hyg 77 39 40
78. Z Sheir AA Nasr A Massoud O Salama GA Badra H El-Shennawy N Hassan SM Hammad 2001 A safe, effective, herbal antischistosomal therapy derived from myrrh Am J Trop Med Hyg 65 700 704
79. U Staudt G Schmahl G Blaschke H Mehlhorn 1992 Light and scanning electron microscopy studies on the effects of the enantiomers of praziquantel and its main metabolite on Schistosoma mansoni in vitro Parasitol Res 78 392 397
80. P Steinmann J Keiser R Bos M Tanner J Utzinger 2006 Schistosomiasis and water resources development: systematic review, meta-analysis and estimates of people at risk Lancet Infect Dis 6 411 425
81. FF Stelma I Talla S Sow A Kongs M Niang K Polman AM Deelder B Gryseels 1995 Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni Am J Trop Med Hyg 53 167 170
82. HA Titulaer J Zuidema PA Kager JC Wetsteyn CB Lugt FW Merkus 1990 The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers J Pharm Pharmacol 42 810 813
83. J Utzinger EK N'Goran A N'Dri C Lengeler SH Xiao M Tanner 2000 Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial Lancet 355 1320 1325
84. J Utzinger J Chollet J You J Mei M Tanner S Xiao 2001 Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals Acta Trop 80 9 18
85. J Utzinger S Xiao J Keiser M Chen J Zheng M Tanner 2001 Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites Curr Med Chem 8 1841 1860
86. J Utzinger SH Xiao EK N'Goran R Bergquist M Tanner 2001 The potential of artemether for the control of schistosomiasis Int J Parasitol 31 1549 1562
87. J Utzinger J Chollet Z Tu S Xiao M Tanner 2002 Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice Trans R Soc Trop Med Hyg 96 318 323
88. J Utzinger J Keiser SH Xiao M Tanner BH Singer 2003 Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials Antimicrob Agents Chemother 47 1487 1495
89. J Utzinger SH Xiao M Tanner J Keiser 2007 Artemisinins for schistosomiasis and beyond Curr Opin Investig Drugs 8 105 116
90. L van Lieshout FF Stelma F Guisse ST Falcao Ferreira K Polman GJ van Dam M Diakhate S Sow A Deelder B Gryseels 1999 The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal Am J Trop Med Hyg 61 760 765
91. JL Vennerstrom S Arbe-Barnes R Brun SA Charman FCK Chiu J Chollet Y Dong A Dorn D Hunziker H Matile K McIntosh M Padmanilayam J Santo Tomas C Scheurer B Scorneaux Y Tang H Urwyler S Wittlin WN Charman 2004 Identification of an antimalarial synthetic trioxolane drug development candidate Nature 430 900 904
92. G Webbe C James 1977 A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei in hamsters Z Parasitenkd 52 169 177
93. LT Webster Jr 1990
94. WHO (2001) Antimalarial drug combination therapy. Report of a WHO Technical Consultation (document WHO/CDS/RBM/2001.35)
95. WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech Rep Ser No. 912
96. SH Xiao BA Catto 1989 Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni J Infect Dis 159 589 592
97. SH Xiao BA Catto 1989 In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni Antimicrob Agents Chemother 33 1557 1562
98. SH Xiao JW Yin JY Mei JQ You Y Li HJ Jiang 1992 Effect of arteether on Schistosoma japonicum Acta Pharm Sin 27 161 165
99. SH Xiao J Chollet M Booth NA Weiss M Tanner 1999 Therapeutic effect of praziquantel enantiomers in mice infected with Schistosoma mansoni Trans R Soc Trop Med Hyg 93 324 325
100. SH Xiao M Booth M Tanner 2000 The prophylactic effects of artemether against Schistosoma japonicum infections Parasitol Today 16 122 126
101. SH Xiao J Chollet NA Weiss RN Bergquist M Tanner 2000 Preventive effect of artemether in experimental animals infected with Schistosoma mansoni Parasitol Int 49 19 24
102. SH Xiao S Binggui J Chollet M Tanner 2000 Tegumental changes in 21-day-old Schistosoma mansoni harboured in mice treated with artemether Acta Trop 75 341 348
103. SH Xiao J Chollet J Utzinger H Matile J Mei M Tanner 2001 Artemether administered together with haemin damages schistosomes in vitro Trans R Soc Trop Med Hyg 95 67 71
104. SH Xiao M Tanner EK N'Goran J Utzinger J Chollet R Bergquist M Chen J Zheng 2002 Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia Acta Trop 82 175 181
105. S Xiao Y Yang Q You J Utzinger H Guo J Peiying J Mei J Guo R Bergquist M Tanner 2002 Potential long-term toxicity of repeated orally administered doses of artemether in rats Am J Trop Med Hyg 66 30 34
106. SH Xiao J Keiser J Chollet J Utzinger Y Dong Y Endriss JL Vennerstrom M Tanner 2007 In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species Antimicrob Agents Chemother 51 1440 1445
107. M Xu 1998 The progress on prophylactic studies of artemisinin, artemether and artesunate against schistosomiasis japonica Chin J Schistosomiasis Control 10 251 253
108. JW Yin YQ Yang SH Xiao Y Li HJ Jiang 1991 Comparative studies on histological and histochemical alterations of Schistosoma japonicum induced by arteether and artemether Acta Pharm Sin 12 478 480